Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kiboukai Medical Corporation is a Japanese healthcare organization that operates a network of specialized clinics focusing on dialysis, cardiovascular health, and regenerative medicine. The corporation is recognized for providing advanced therapeutic options, including mesenchymal stem cell (MSC) therapies, to treat chronic conditions such as kidney disease and metabolic disorders. Kiboukai integrates clinical expertise with innovative medical technologies to improve patient outcomes across its facilities in Japan. The organization operates under Japan's unique regulatory framework for regenerative medicine, offering cell-based treatments directly to patients in a clinical setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kiboukai.